Showing results (51-60 of 283) with videos related to
Sort By:
Pageof 29
Australian and New Zealand Journal of Medicine|October 1, 1982
Reversible renal failure due to renal cholesterol embolismS W Ho, G N Thatcher, L R MatzInternational Journal of Cancer|March 15, 1989
Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2A K Ghosh, H Dazzi, N Thatcher, et al.British Journal of Cancer|March 1, 1990
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studiesA K Ghosh, M Mellor, J Prendiville, et al.British Journal of Cancer|April 1, 1986
Genetic predisposition to human lung cancerJ Heighway, N Thatcher, T Cerny, et al.British Journal of Diseases of the Chest|April 1, 1983
A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small-cell bronchogenic carcinoma of limited extentK B Carroll, H Moussalli, D Brown, et al.British Journal of Diseases of the Chest|April 1, 1985
Upper abdominal lymphadenopathy as first presentation of relapse, identified by ultrasonography, in patients treated for small cell (oat cell) bronchogenic carcinomaD Smith, R Johnson, R D James, et al.Seminars in Oncology|February 1, 1992
Novel approaches with ifosfamide in small cell lung cancerN Thatcher, M Lind, E De Campos, et al.British Journal of Cancer|December 1, 1986
Pulmonary carcinoid tumours: a clinico-pathological study of 35 casesP S Hasleton, S Gomm, V Blair, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study with mitomycin, ifosfamide and carboplatin in inoperable non-small cell lung cancerA von Rohr, H Anderson, R McIntosh, et al.British Journal of Cancer|December 1, 1977
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanomaN Thatcher, M K Palmer, N Gasiunas, et al.Pageof 29